TIDMZOE
RNS Number : 6397H
Zoetic International PLC
26 March 2020
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO
CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE
MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON THE PUBLICATION OF
THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE
IN THE PUBLIC DOMAIN.
26 March 2020
Zoetic International plc
("Zoetic" or the "Company")
Issue of Equity
Zoetic, the London listed vertically integrated CBD company, i s
pleased to announce that Ox Distributing, LLC ("Ox Distributing")
has subscribed for 23,750,000 new ordinary shares of 1 pence each
in the capital of the Company ("Ordinary Shares") at a price of 5
pence each for a total consideration of GBP1,187,500 (the
"Subscription").
Ox Distributing, which is owned by the Schrader family, is
Zoetic's primary distribution partner in the United States and is
part of the same group that owns the Schrader Oil convenience
stores through which Zoetic's Chill products are sold. The
Subscription was facilitated by the exercise of 23,750,000 warrants
by Robert Price, the Company's former CEO, at 5 pence each. Mr
Price agreed that the Company could issue the ordinary shares to Ox
Distributing in lieu of payment by him for the warrant
exercise.
In recognition that Zoetic's share price has been volatile
during the current Covid-19 crisis and that the Company's Ordinary
Shares have traded at below 5 pence this week, Zoetic and Ox
Distributing have entered into a loan note instrument pursuant to
which Ox Distributing will settle the consideration for the
Subscription in 10 equal instalments of GBP118,750 each between 30
April 2020 and 31 January 2021. Ox Distributing may, at its
discretion, elect to settle the consideration more quickly. The
loan note instrument provides that interest will accrue on the
outstanding consideration until such time as it is settled and,
furthermore, a penalty interest rate will apply in the event that
any monthly instalments are missed or delayed.
In a separate transaction, a second warrant holder has exercised
60,000 warrants, also at 5 pence each. Zoetic has also agreed with
this warrant holder that he may pay for the resulting 60,000
ordinary shares over 10 months on similar terms to the loan note
with Ox Distributing.
A further 2,750,000 warrants have expired unexercised. The
Company now has no further warrants or options in issue aside from
7,155,000 share option awards to staff, exercisable at 10 pence per
Ordinary Share, and 1,000,000 share options granted to Stephen
Goldman, exercisable at 12 pence per Ordinary Share.
Application will be made for an additional 23,810,000 ordinary
shares in the Company (the "New Ordinary Shares") to be admitted to
trading on the Official List of the UK Listing Authority by way of
a Standard Listing and to trading on the London Stock Exchange's
Main Market for listed securities ("Admission"). Admission is
expected to take place on 1 April 2020.
Following Admission, the New Ordinary Shares will rank pari
passu in all respects with the existing Ordinary Shares in issue,
including the right to receive all dividends and other
distributions declared, and the total number of Ordinary Shares
with voting rights will be 172,920,034. This figure may be used by
Zoetic International shareholders as the denominator for
calculations to determine if they have a notifiable interest in
Zoetic International under the Disclosure and Transparency Rules,
or if such interest has changed.
Following Admission, the Schrader family's holding of 24,750,000
ordinary shares will represent 14.31% of the Company's total voting
rights and Robert Price's existing holding of 11,440,000 ordinary
shares will represent 6.62% of the Company's total voting
rights.
Director remuneration and staff responsibilities
Following on from the cost savings announced last week, Paul
Mendell, Zoetic's Chairman, has informed the Company that he will
continue to waive any remuneration for his role. Furthermore, for
the duration of the Covid-19 crisis and whilst the Company is
running on a lower headcount and at a lower cost, several members
of staff have been asked to take on additional responsibilities to
cover work done by former members of the team. No one is receiving
any additional remuneration for these additional
responsibilities.
Nick Tulloch, Chief Executive of Zoetic, said:
" On behalf of the entire Zoetic team, I would like to thank Ox
Distributing and the Schrader family for their support. In the
midst of one of the greatest economic and health crises in memory,
and when many investors are being highly cautious about entering
into new commitments, the confidence they are showing in our
ability to succeed in our business plan is truly flattering.
"As I mentioned in our update last week , with our two CBD
brands and inventory of feminised hemp seeds, we were poised to
make significant advances in our business this month. The
challenges presented by Covid-19 mean that we need to reassess our
timing, but we continue to work on the basis that it is a case of
when and not if. This new financial support has given us far
greater scope to navigate our Company through these difficult
times."
**ENDS**
Enquiries
Zoetic International plc +44 (0) 1738 472 029
Nick Tulloch
Allenby Capital Limited (Financial Adviser and Broker) +44 (0)
20 3328 5656
Nick Harriss
Nick Naylor
IFC Advisory Ltd (Financial PR and IR) +44 (0) 20 3934 6630
Tim Metcalfe
Graham Herring
Florence Chandler
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
IOELELLLBXLXBBK
(END) Dow Jones Newswires
March 26, 2020 03:00 ET (07:00 GMT)
Highlands Natural Resour... (LSE:HNR)
Historical Stock Chart
From Apr 2024 to May 2024
Highlands Natural Resour... (LSE:HNR)
Historical Stock Chart
From May 2023 to May 2024